These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6439845)

  • 1. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: effective dose, time, route, and number of vaccinations.
    Ritter DM; Rowland EC
    J Parasitol; 1984 Oct; 70(5):755-9. PubMed ID: 6439845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus Christi strain-induced protection to Trypanosoma cruzi infection in C3H(He) mice: transfer of resistance to Brazil strain challenge with lymphocytes.
    Rowland EC; Ritter DM
    J Parasitol; 1984 Oct; 70(5):760-6. PubMed ID: 6439846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
    Tarleton RL
    J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
    Mikhail KS; Rowland EC
    J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence.
    Rowland E; Luo H; McCormick T
    J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of antibody cross-reactivity in experimental American trypanosomiasis.
    Rosfjord EC; Mikhail KS; Rowland EC; Powell MR
    J Parasitol; 1990 Oct; 76(5):698-702. PubMed ID: 1698959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of the epimastigote forms of the PF strain of Trypanosoma cruzi against a virulent homologous infection.
    Menezes H
    Tropenmed Parasitol; 1976 Dec; 27(4):418-21. PubMed ID: 827037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and characterization of clones of the Brazil strain of Trypanosoma cruzi.
    Murfin DJ; Choromanski L; Kuhn RE
    J Parasitol; 1985 Oct; 71(5):525-9. PubMed ID: 3932632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
    Basombrio MA; Mora MC; Segura MA
    Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
    Basombrío MA; Segura MA; Nasser JR
    J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
    Hoft DF; Lynch RG; Kirchhoff LV
    J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response.
    Miller MJ; Wrightsman RA; Manning JE
    Exp Parasitol; 1996 Nov; 84(2):156-67. PubMed ID: 8932765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain specific protective immunity against Trypanosoma cruzi.
    Kloetzel JK; Lafaille JJ
    J Parasitol; 1983 Apr; 69(2):267-70. PubMed ID: 6406657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.